Loading provider…
Loading provider…
Pulmonary Disease Physician in San Diego, CA
NPI: 1134145949Primary Employer
UCSD Medical Group
health.ucsd.edu
HQ Phone
Get M.D. Gordon's Phone NumberMobile
Get M.D. Gordon's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1995 - 2027

American Board of Internal Medicine
Critical Care Medicine

American Board of Internal Medicine
Pulmonary Disease
University of California (San Diego) Medical Center
Fellowship • Pulmonary Disease and Critical Care Medicine
1995 - 1998
New York Downtown Hospital
Residency • Internal Medicine
1992 - 1995
University of Hong Kong Faculty of Medicine
Medical School
Until 1986
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 149 | 280 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 85 | 151 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 32 | 81 |
| 4 | 31624Irrigation and suction of lung airways to obtain cells using an endoscope | 26 | 37 |
| 5 | 99152Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | 23 | 27 |
Authors: Robin Avery, Robert Davis, Aaron Milstone, Vincent Valentine, Aaron Milstone
Journal: Ann Intern Med
Low dose posaconazole delayed release tablets for fungal prophylaxis in lung transplant recipients.
Lead Sponsor: FibroGen
Intervention / Treatment: DRUG: Placebo, DRUG: Pamrevlumab
Lead Sponsor: Gilead Sciences
Intervention / Treatment: DRUG: Simtuzumab placebo, DRUG: Simtuzumab